Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishakantha Murthy

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cellular and Molecular Neurobiology|March 28, 2015
Reward and Toxicity of Cocaine Metabolites Generated by Cocaine HydrolaseVishakantha Murthy, Liyi Geng, Yang Gao, et al.
Vaccine|June 4, 2014
Physiologic and metabolic safety of butyrylcholinesterase gene therapy in miceVishakantha Murthy, Yang Gao, Liyi Geng, et al.
The Journal of Pharmacy and Pharmacology|October 15, 2013
Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's diseaseJayasankar Kosaraju, Vishakantha Murthy, Rizwan Basha Khatwal, et al.
Neuropharmacology|June 15, 2014
SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase CSang-Min Lee, Andrew Kant, Daniel Blake, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 26, 2015
Pharmacokinetic and tissue distribution studies of 1,9-pyrazoloanthrone, a c-Jun-N-terminal kinase inhibitor in Wistar rats by a simple and sensitive HPLC methodNilesh Sudhakar Ambhore, Karthik Yamjala, Shubhashri Mohire, et al.
Iranian Journal of Pharmaceutical Research : IJPR|March 20, 2018
Brain Targeting of 1,9-Pyrazoloanthrone an c-Jun-N-terminal Kinase Inhibitor Using Liposomes for Effective Management of Parkinson's DiseaseNilesh Sudhakar Ambhore, Kalidhindi Rama Satyanarayana Raju, Shashank Mulukutla, et al.
Medical Hypotheses|December 9, 2015
Salicylic acid derivatives as potential anti asthmatic agents using disease responsive drug delivery system for prophylactic therapy of allergic asthmaKalidhindi Rama Satyanarayana Raju, Nilesh S Ambhore, Shashank Mulukutla, et al.
Journal of the American Heart Association|June 14, 2022
Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI TrialMina Madan, J Dawn Abbott, Ryan Lennon, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 12, 2019
Clinical and Biochemical Phenotypes in a Family With ENPP1 MutationsAnupam Kotwal, Alejandro Ferrer, Rajiv Kumar, et al.
Pulmonary Pharmacology & Therapeutics|August 8, 2014
5-Aminosalicylic acid attenuates allergen-induced airway inflammation and oxidative stress in asthmaK Rama Satyanarayana Raju, M N Sathish Kumar, Saurabh Gupta, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cellular and Molecular Neurobiology|March 28, 2015
Reward and Toxicity of Cocaine Metabolites Generated by Cocaine HydrolaseVishakantha Murthy, Liyi Geng, Yang Gao, et al.
Vaccine|June 4, 2014
Physiologic and metabolic safety of butyrylcholinesterase gene therapy in miceVishakantha Murthy, Yang Gao, Liyi Geng, et al.
The Journal of Pharmacy and Pharmacology|October 15, 2013
Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's diseaseJayasankar Kosaraju, Vishakantha Murthy, Rizwan Basha Khatwal, et al.
Neuropharmacology|June 15, 2014
SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase CSang-Min Lee, Andrew Kant, Daniel Blake, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 26, 2015
Pharmacokinetic and tissue distribution studies of 1,9-pyrazoloanthrone, a c-Jun-N-terminal kinase inhibitor in Wistar rats by a simple and sensitive HPLC methodNilesh Sudhakar Ambhore, Karthik Yamjala, Shubhashri Mohire, et al.
Iranian Journal of Pharmaceutical Research : IJPR|March 20, 2018
Brain Targeting of 1,9-Pyrazoloanthrone an c-Jun-N-terminal Kinase Inhibitor Using Liposomes for Effective Management of Parkinson's DiseaseNilesh Sudhakar Ambhore, Kalidhindi Rama Satyanarayana Raju, Shashank Mulukutla, et al.
Medical Hypotheses|December 9, 2015
Salicylic acid derivatives as potential anti asthmatic agents using disease responsive drug delivery system for prophylactic therapy of allergic asthmaKalidhindi Rama Satyanarayana Raju, Nilesh S Ambhore, Shashank Mulukutla, et al.
Journal of the American Heart Association|June 14, 2022
Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI TrialMina Madan, J Dawn Abbott, Ryan Lennon, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 12, 2019
Clinical and Biochemical Phenotypes in a Family With ENPP1 MutationsAnupam Kotwal, Alejandro Ferrer, Rajiv Kumar, et al.
Pulmonary Pharmacology & Therapeutics|August 8, 2014
5-Aminosalicylic acid attenuates allergen-induced airway inflammation and oxidative stress in asthmaK Rama Satyanarayana Raju, M N Sathish Kumar, Saurabh Gupta, et al.
Pageof 3